Amantadine reduces persistent fatigue during post-acute withdrawal phase in methamphetamine abstained individuals: A randomized placebo-controlled trial

References

• Alterman, A. I., Droba, M., Antelo, R. E., Cornish, J. W., Sweeney, K. K., Parikh, G. A., & O’Brien, C. P. (1992). Amantadine may facilitate detoxification of cocaine addicts. Drug and Alcohol Dependence, 31, 19–29. doi:10.1016/0376-8716(92)90004-V
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (2000). Diagnostic criteria from DSM-IV-TR. Washington, DC: Author.
   Google Scholar
• Ashtari, F., Fatehi, F., Shaygannejad, V., & Chitsaz, A. (2009). Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis? Neurologia I Neurochirurgia Polska, 43, 428–432.
   PubMed Web of Science ®Google Scholar
• Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993). Development of a fatigue scale. Journal of Psychosomatic Research, 37, 147–153. doi:10.1016/0022-3999(93)90081-P
   PubMed Web of Science ®Google Scholar
• Ciccarone, D. (2011). Stimulant abuse: Pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Primary Care, 38, 41–58, v–vi. doi:10.1016/j.pop.2010.11.004
   PubMed Web of Science ®Google Scholar
• Cruickshank, C. C., & Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction, 104, 1085–1099. doi:10.1111/add.2009.104.issue-7
   PubMed Web of Science ®Google Scholar
• Danaee-Far, M., Maarefvand, M., & Rafiey, H. (2016). Effectiveness of a brief home-based social work motivational intervention for male methamphetamine users in Tehran: A randomized clinical trial. Substance Use & Misuse, 51, 1863–1869. doi:10.1080/10826084.2016.1200620
   PubMed Web of Science ®Google Scholar
• de Lima, M. S., de Oliveira Soares, B. G., Reisser, A. A., & Farrell, M. (2002). Pharmacological treatment of cocaine dependence: A systematic review. Addiction, 97, 931–949. doi:10.1046/j.1360-0443.2002.00209.x
   PubMed Web of Science ®Google Scholar
• Fairbairn, C. E., Dundon, W. D., Xie, H., Plebani, J. G., Kampman, K. M., & Lynch, K. G. (2008). Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trial. The American Journal on Addictions, 17, 387–391. doi:10.1080/10550490802266078
   PubMed Web of Science ®Google Scholar
• Fereshtehnejad, S. M., Hadizadeh, H., Farhadi, F., Shahidi, G. A., Delbari, A., & Lokk, J. (2013). Reliability and validity of the persian version of the fatigue severity scale in idiopathic Parkinson’s disease patients. Parkinson’s Disease, 2013, 935429.
   PubMed Web of Science ®Google Scholar
• Flo, E., & Chalder, T. (2014). Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice. Behaviour Research and Therapy, 63, 1–8. doi:10.1016/j.brat.2014.08.013
   PubMed Web of Science ®Google Scholar
• Foroughipour, M., Bahrami Taghanaki, H. R., Saeidi, M., Khazaei, M., Sasannezhad, P., & Shoeibi, A. (2013). Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: An observational study. Acupuncture in Medicine, 31, 27–30. doi:10.1136/acupmed-2012-010199
   PubMed Web of Science ®Google Scholar
• Gonzales, R., Mooney, L., & Rawson, R. A. (2010). The methamphetamine problem in the United States. Annual Review of Public Health, 31, 385–398. doi:10.1146/annurev.publhealth.012809.103600
   PubMed Web of Science ®Google Scholar
• Hart, C. L., Haney, M., Foltin, R. W., & Fischman, M. W. (2002). Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl), 164, 376–384. doi:10.1007/s00213-002-1225-9
   PubMed Web of Science ®Google Scholar
• Hubsher, G., Haider, M., & Okun, M. S. (2012). Amantadine: The journey from fighting flu to treating Parkinson disease. Neurology, 78, 1096–1099. doi:10.1212/WNL.0b013e31824e8f0d
   PubMed Web of Science ®Google Scholar
• Jason, L. A, Evans, M, Brown, M, Porter, N, Brown, A, Hunnell, J, & Lerch, A. (2011). Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity. Disability Studies Quarterly, 31, 1–15.
   Google Scholar
• Kampman, K. M., Volpicelli, J. R., Alterman, A. I., Cornish, J., & O’Brien, C. P. (2000). Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms. The American Journal of Psychiatry, 157, 2052–2054. doi:10.1176/appi.ajp.157.12.2052
   PubMed Web of Science ®Google Scholar
• Karila, L., Weinstein, A., Aubin, H. J., Benyamina, A., Reynaud, M., & Batki, S. L. (2010). Pharmacological approaches to methamphetamine dependence: A focused review. British Journal of Clinical Pharmacology, 69, 578–592. doi:10.1111/j.1365-2125.2010.03639.x
   PubMed Web of Science ®Google Scholar
• Lee, N., Pennay, A., Hester, R., McKetin, R., Nielsen, S., & Ferris, J. (2013). A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: Feasibility, tolerability and clinical outcomes. Drug and Alcohol Review, 32, 88–95. doi:10.1111/dar.2013.32.issue-1
   PubMed Web of Science ®Google Scholar
• Lerdal, A., Wahl, A., Rustoen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health, 33, 123–130. doi:10.1080/14034940410028406
   PubMed Web of Science ®Google Scholar
• Lubman, D. I., Yucel, M., & Pantelis, C. (2004). Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction, 99, 1491–1502. doi:10.1111/j.1360-0443.2004.00808.x
   PubMed Web of Science ®Google Scholar
• Mahoney, 3rd, J. J., De La Garza, 2nd, R., Jackson, B. J., Verrico, C. D., Ho, A., Iqbal, T., & Newton, T. F. (2014). The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Research, 219, 367–371. doi:10.1016/j.psychres.2014.05.026
   PubMed Web of Science ®Google Scholar
• Mahoney, J. J., Jackson, B. J., Kalechstein, A. D., De La Garza, 2nd, R., Chang, L. C., & Newton, T. F. (2012). Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology, 15, 1241–1249. doi:10.1017/S1461145711001805
   PubMed Web of Science ®Google Scholar
• McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction, 100, 1320–1329. doi:10.1111/add.2005.100.issue-9
   PubMed Web of Science ®Google Scholar
• Mucke, M., Mochamat, C. H., Peuckmann-Post, V., Minton, O., Stone, P., & Radbruch, L. (2016). Pharmacological treatments for fatigue associated with palliative care: Executive summary of a Cochrane Collaboration systematic review. Journal of Cachexia, Sarcopenia and Muscle, 7, 23–27. doi:10.1002/jcsm.12101
   PubMed Web of Science ®Google Scholar
• Pennay, A. E., & Lee, N. K. (2011). Putting the call out for more research: The poor evidence base for treating methamphetamine withdrawal. Drug and Alcohol Review, 30, 216–222. doi:10.1111/j.1465-3362.2010.00240.x
   PubMed Web of Science ®Google Scholar
• Ren, W., Tao, J., Wei, Y., Su, H., Zhang, J., Xie, Y., … He, J. (2016). Time-dependent serum brain-derived neurotrophic factor decline during methamphetamine withdrawal. Medicine, 95, e2604. doi:10.1097/MD.0000000000002604
   PubMed Web of Science ®Google Scholar
• Romach, M. K., Sellers, E. M., Kaplan, H. L., Fernandes, L. C., Oldenhof, J., & McDonald, S. (2004). Oral ketamine as a positive control in abuse liability studies. Clinical Pharmacology and Therapeutics, 75, P72–P72. doi:10.1016/j.clpt.2003.11.271
   Web of Science ®Google Scholar
• Sears, S. D., & Clements, M. L. (1987). Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus. Antimicrobial Agents and Chemotherapy, 31, 1470–1473. doi:10.1128/AAC.31.10.1470
   PubMed Web of Science ®Google Scholar
• Sharifi, H., Shokoohi, M., Ahmad RafieiRad, A., Sargolzaie Moghadam, M., Haghdoost, A. A., Mirzazadeh, A., & Karamouzian, M. (2017). Methamphetamine use among Iranian youth: A population-based knowledge, attitude, and practice study. Substance Use & Misuse, 1–8.
   PubMed Web of Science ®Google Scholar
• Shaygannejad, V., Janghorbani, M., Ashtari, F., & Zakeri, H. (2012). Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: A randomized, blinded, crossover study. Neurological Research, 34, 854–858. doi:10.1179/1743132812Y.0000000081
   PubMed Web of Science ®Google Scholar
• Shoptaw, S. J., Kao, U., Heinzerling, K., & Ling, W. (2009). Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews, 2, CD003021. doi:10.1002/14651858.CD003021.pub2
   PubMedGoogle Scholar
• Tennant, Jr., F. S., & Sagherian, A. A. (1987). Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Archives of Internal Medicine, 147, 109–112. doi:10.1001/archinte.1987.00370010109025
   PubMed Web of Science ®Google Scholar
• Thrash-Williams, B., Ahuja, M., Karuppagounder, S. S., Uthayathas, S., Suppiramaniam, V., & Dhanasekaran, M. (2013). Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity. Neurochemical Research, 38, 2084–2094. doi:10.1007/s11064-013-1117-x
   PubMed Web of Science ®Google Scholar
• Valko, P. O., Bassetti, C. L., Bloch, K. E., Held, U., & Baumann, C. R. (2008). Validation of the fatigue severity scale in a Swiss cohort. Sleep, 31, 1601–1607. doi:10.1093/sleep/31.11.1601
   PubMed Web of Science ®Google Scholar
• Wang, D., Li, W., Xiao, Y., He, W., Wei, W., Yang, L., … Wang, Z. (2016). Tryptophan for the sleeping disorder and mental symptom of new-type drug dependence: A randomized, double-blind, placebo-controlled trial. Medicine, 95, e4135. doi:10.1097/MD.0000000000004135
   PubMedGoogle Scholar
• White, C. M., Van Doorn, P. A., Garssen, M. P., & Stockley, R. C. (2014). Interventions for fatigue in peripheral neuropathy. In Cochrane database of systematic reviews, 12.
   Google Scholar
• Whitehead, L. (2009). The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management, 37, 107–128. doi:10.1016/j.jpainsymman.2007.08.019
   PubMed Web of Science ®Google Scholar
• Yu, S., Zhu, L., Shen, Q., Bai, X., & Di, X. (2015). Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behavioural Neurology, (2015), 103969.
   PubMedGoogle Scholar
• Zorick, T., Nestor, L., Miotto, K., Sugar, C., Hellemann, G., Scanlon, G., … Ed, L. (2010). Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction, 105, 1809–1818. doi:10.1111/j.1360-0443.2010.03066.x
   PubMed Web of Science ®Google Scholar